ECB-ART-52156
CNS Neurosci Ther
2023 Jun 01;29 Suppl 1Suppl 1:213-219. doi: 10.1111/cns.13988.
Show Gene links
Show Anatomy links
Getting the guts to expand stroke treatment: The potential for microbiome targeted therapies.
Monsour M
,
Croci DM
,
Agazzi S
,
Borlongan CV
.
???displayArticle.abstract???
AIMS: This review focuses on the recent literature regarding the role of the gut-brain axis (GBA) following ischemic stroke. DISCUSSION: Stroke is the 5th leading cause of death and disability in the United States; however, few therapies have been developed to improve prognoses. There is a plethora of evidence suggesting peripheral inflammatory responses play a large role in the pathogenesis of stroke. Additionally, hyperglycemic conditions may play a significant role in worsening stroke outcomes due to microbiome dysbiosis. CONCLUSION: Recent research has illuminated the vital role of the GBA in propagating poor clinical outcomes, such as hemorrhagic transformation, following ischemic stroke. Considering this detrimental consequence of stroke, and the apparent role of the GBA role, future therapeutics should aim to mitigate this peripheral contribution to stroke complications.
???displayArticle.pubmedLink??? 36217699
???displayArticle.link??? CNS Neurosci Ther
References [+] :
Acosta,
Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
2015, Pubmed
Acosta, Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. 2015, Pubmed
Andersen, Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. 2009, Pubmed
Anrather, Inflammation and Stroke: An Overview. 2016, Pubmed
Anthony, Neuroinflammation, Stem Cells, and Stroke. 2022, Pubmed
Arya, Brain-gut axis after stroke. 2018, Pubmed
Benakis, Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. 2016, Pubmed
Borlongan, IL-2/IL-2R Antibody Complex Enhances Treg-Induced Neuroprotection by Dampening TNF-α Inflammation in an In Vitro Stroke Model. 2021, Pubmed
Chen, Puerariae Lobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. 2019, Pubmed
Chey, Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. 2011, Pubmed
Cho, Gut dysbiosis in stroke and its implications on Alzheimer's disease-like cognitive dysfunction. 2021, Pubmed
Derrien, Mucin-bacterial interactions in the human oral cavity and digestive tract. 2010, Pubmed
Durgan, Examining the Role of the Microbiota-Gut-Brain Axis in Stroke. 2019, Pubmed
Feigin, Stroke is largely preventable across the globe: where to next? 2016, Pubmed
Gao, Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. 2006, Pubmed
Gumbinger, Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials. 2014, Pubmed
Gzielo, The Impact of the Ketogenic Diet on Glial Cells Morphology. A Quantitative Morphological Analysis. 2019, Pubmed
Haak, Disruptions of Anaerobic Gut Bacteria Are Associated with Stroke and Post-stroke Infection: a Prospective Case-Control Study. 2021, Pubmed
Hankey, Potential new risk factors for ischemic stroke: what is their potential? 2006, Pubmed
Hawkins, Structure of the blood-brain barrier and its role in the transport of amino acids. 2006, Pubmed
Houlden, Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. 2016, Pubmed
Huang, Alterations in the gut microbiome with hemorrhagic transformation in experimental stroke. 2022, Pubmed
Jang, Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease. 2020, Pubmed
Kaesmacher, Hemorrhagic Transformations after Thrombectomy: Risk Factors and Clinical Relevance. 2017, Pubmed
Kaneko, Translating intracarotid artery transplantation of bone marrow-derived NCS-01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy. 2020, Pubmed
Karlsson, Symptomatic atherosclerosis is associated with an altered gut metagenome. 2012, Pubmed
Kawabori, Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke. 2020, Pubmed
Kernan, Obesity: a stubbornly obvious target for stroke prevention. 2013, Pubmed
Khan, Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice. 2020, Pubmed
Kim, The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. 2009, Pubmed
Kingsbury, Inflammation-relevant microbiome signature of the stroke brain, gut, spleen, and thymus and the impact of exercise. 2021, Pubmed
Koeth, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. 2013, Pubmed
Le Chatelier, Richness of human gut microbiome correlates with metabolic markers. 2013, Pubmed
Lees, Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. 2010, Pubmed
Li, Change of intestinal microbiota in cerebral ischemic stroke patients. 2019, Pubmed
Lippert, Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. 2017, Pubmed
Liu, Gut microbiota interacts with intrinsic brain activity of patients with amnestic mild cognitive impairment. 2021, Pubmed
Liu, Comparison of two rat models of cerebral ischemia under hyperglycemic conditions. 2007, Pubmed
Liu, Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. 2009, Pubmed
Mao, Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke. 2017, Pubmed
Marcet, When friend turns foe: central and peripheral neuroinflammation in central nervous system injury. 2017, Pubmed
McColl, Systemic inflammation and stroke: aetiology, pathology and targets for therapy. 2007, Pubmed
Miró-Mur, Adrenal hormones and circulating leukocyte subtypes in stroke patients treated with reperfusion therapy. 2018, Pubmed
Monsour, The role of IL-6 in TBI and PTSD, a potential therapeutic target? 2022, Pubmed
Mozaffarian, Heart disease and stroke statistics--2015 update: a report from the American Heart Association. 2015, Pubmed
Nguyen, Eye Opener in Stroke. 2019, Pubmed
Nicholson, Host-gut microbiota metabolic interactions. 2012, Pubmed
Park, The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats. 2016, Pubmed
Qin, A metagenome-wide association study of gut microbiota in type 2 diabetes. 2012, Pubmed
Rong, [Effect of intermittent fasting on physiology and gut microbiota in presenium rats]. 2016, Pubmed
Sadler, Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms. 2020, Pubmed
Shinozuka, Stem Cells for Neurovascular Repair in Stroke. 2013, Pubmed
Singh, Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke. 2016, Pubmed
Smith, The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. 2013, Pubmed
Soares, Does intermittent fasting associated with aerobic training influence parameters related to the gut-brain axis of Wistar rats? 2021, Pubmed
Stonesifer, Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. 2017, Pubmed
Suzuki, Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy. 2021, Pubmed
Tang, Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. 2013, Pubmed
Tillisch, Brain Structure and Response to Emotional Stimuli as Related to Gut Microbial Profiles in Healthy Women. 2017, Pubmed
Toledo, Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders. 2022, Pubmed , Echinobase
Torres-Rosas, Dopamine mediates vagal modulation of the immune system by electroacupuncture. 2014, Pubmed
Utzschneider, Mechanisms Linking the Gut Microbiome and Glucose Metabolism. 2016, Pubmed
Vital, Colonic Butyrate-Producing Communities in Humans: an Overview Using Omics Data. 2017, Pubmed
Wang, Gut Microbiota-brain Axis. 2016, Pubmed
Wang, The inflammatory response in stroke. 2007, Pubmed
Wells, Epithelial crosstalk at the microbiota-mucosal interface. 2011, Pubmed
Xia, Stroke Dysbiosis Index (SDI) in Gut Microbiome Are Associated With Brain Injury and Prognosis of Stroke. 2019, Pubmed
Xu, Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn. 2021, Pubmed
Yamashiro, Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. 2017, Pubmed
Yin, Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack. 2015, Pubmed
Zhao, Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders. 2014, Pubmed
Zhao, Exposed to Mercury-Induced Oxidative Stress, Changes of Intestinal Microflora, and Association between them in Mice. 2021, Pubmed
Zhao, Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats. 2021, Pubmed
Zhao, New Insights into Stroke Prevention and Treatment: Gut Microbiome. 2022, Pubmed